利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

81 条记录 (耗时 0.037 秒)

    Systems and methods for providing supplemental power to battery powered information handling systems
    2.
    发明授权
    Systems and methods for providing supplemental power to battery powered information handling systems 有权
    为电池供电的信息处理系统提供补充电力的系统和方法

    公开(公告)号：US08793518B2

    公开(公告)日：2014-07-29

    申请号：US13495631

    申请日：2012-06-13

    申请人： Karunakar P. Reddy

    发明人： Karunakar P. Reddy

    IPC分类号： G06F1/00 ,  H02J7/00

    CPC分类号： G06F1/3212 ,  Y02D10/174

    摘要： Systems and methods are disclosed for providing supplemental power to a battery powered information handling systems. The disclosed systems and methods may be implemented to intelligently control the selected use of supplemental power so as to reduce or substantially prevent an increase in battery usage cycle count by only allowing use of supplemental power above a given minimum supplemental battery charge level threshold. Battery cycle count may be further enhanced by only again allowing recharging of the system battery pack when its charge level drops below the minimum supplemental battery charge level threshold, and then recharging to a maximum recharge battery charge level threshold which also may be selectable by a user and/or provider of the information handling system.

    摘要翻译： 公开了用于向电池供电的信息处理系统提供补充电力的系统和方法。 所公开的系统和方法可以被实现为智能地控制所选择的补充功率的使用，以便通过仅允许使用高于给定的最小补充电池电量级别阈值的补充功率来减少或基本上防止电池使用周期计数的增加。 当电池电量降低到最低补充电池电量阈值以下时，再次允许系统电池组再充电，然后再充电到也可由用户选择的最大充电电池充电电平阈值，可以进一步增强电池循环计数 和/或信息处理系统的提供者。

    PYRAZALIDINONE COMPOUNDS AS LIGANDS OF THE PROSTAGLANDIN EP2 AND/OR EP4 RECEPTORS
    4.
    发明申请
    PYRAZALIDINONE COMPOUNDS AS LIGANDS OF THE PROSTAGLANDIN EP2 AND/OR EP4 RECEPTORS 失效
    作为PROSTAGLANDIN EP2和/或EP4受体的配体的吡唑烷酮化合物

    公开(公告)号：US20080234346A1

    公开(公告)日：2008-09-25

    申请号：US12120408

    申请日：2008-05-14

    申请人： Gian Luca ARALDI ,  Yihua Liao ,  Adulla P. Reddy ,  Zhong Zhao

    发明人： Gian Luca ARALDI ,  Yihua Liao ,  Adulla P. Reddy ,  Zhong Zhao

    IPC分类号： A61K31/4152 ,  C07D231/04 ,  A61P15/00 ,  A61P11/00 ,  A61P7/00

    CPC分类号： A61K31/4152 ,  C07D231/08

    摘要： The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing preterm labor, dysmenorrhea, asthma, hypertension, infertility or fertility disorder, undesired blood clotting, preeclampsia or eclampsia, an eosinophil disorder, sexual dysfunction, osteporosis and other destructive bone disease or disorder, and other diseases and disorders associated with the prostaglandin EP2 and/or EP4 receptors.

    摘要翻译： 本发明提供取代的吡唑烷酮化合物，以及使用或包含一种或多种这些化合物的治疗方法和药物组合物。 本发明的化合物可用于多种疗法，包括治疗或预防早产，痛经，哮喘，高血压，不育症或生育障碍，不期望的血液凝固，先兆子痫或子痫，嗜酸性粒细胞紊乱，性功能障碍，骨质疏松症和其他破坏性骨 疾病或病症，以及与前列腺素EP2和/或EP4受体相关的其它疾病和病症。

    Multidimensional database system with intermediate lockable intersections
    6.
    发明授权
    Multidimensional database system with intermediate lockable intersections 有权
    具有中间可锁定交叉点的多维数据库系统

    公开(公告)号：US06658413B1

    公开(公告)日：2003-12-02

    申请号：US09653107

    申请日：2000-08-31

    申请人： Venugopal P. Reddy ,  Harmindar S. Matharu

    发明人： Venugopal P. Reddy ,  Harmindar S. Matharu

    IPC分类号： G06F1730

    CPC分类号： G06F17/30592 ,  G06F17/30362 ,  Y10S707/99932 ,  Y10S707/99938 ,  Y10S707/99939 ,  Y10S707/99942

    摘要： A multi-dimensional database includes hierarchical levels. The data is hierarchical, with aggregatable data measures, so that changes in a first intersection will cause changes in other intersections for the aggregated measure. Selected intersections can be locked, so that changes in aggregatable data are restricted. Constrained sets corresponding to the locked intersections limit the scope of changes which may be made, and ensure a high level of efficiency.

    摘要翻译： 多维数据库包括分层级别。 数据是分层的，具有可聚合数据测量，因此第一个交叉点的更改将导致聚合度量的其他交点的更改。 可以锁定所选的交点，以便可聚合数据的更改受到限制。 对应于锁定交叉口的约束集限制了可能发生的变化的范围，并确保高效率。

    Arm rehabilitation and testing device
    8.
    发明授权
    Arm rehabilitation and testing device 失效
    手臂康复和检测装置

    公开(公告)号：US5170777A

    公开(公告)日：1992-12-15

    申请号：US635725

    申请日：1990-12-28

    申请人： Narender P. Reddy ,  John P. Roman ,  Jeffrey P. Bulgrin

    发明人： Narender P. Reddy ,  John P. Roman ,  Jeffrey P. Bulgrin

    IPC分类号： A61H1/02

    CPC分类号： A61H1/0274

    摘要： Disclosed is a motor driven arm rehabilitation device which includes a rotatable forearm support structure capable of being rotated back and forth through a predetermined arc at a predetermined speed and with a predetermined force applied, and a fluid motor such as a rotary actuator for rotating this support structure. Rotation of the supporting structure causes alternate flexion and extension of the patient's arm. The arc of rotation, frequency of rotation and force applied can be varied in accordance with the patient's needs. Associated with the forearm supporting structure is a wrist stabilizer which causes alternate pronation and supination of the wrist as the forearm is alternately flexed and extended. The device also has an upper arm supporting structure.

    摘要翻译： 公开了一种马达驱动臂修复装置，其包括可旋转的前臂支撑结构，其能够以预定的速度以预定的速度和预定的力来回旋转预定的力;以及流体马达，例如用于旋转该支撑件的旋转致动器 结构体。 支撑结构的旋转导致患者手臂的交替屈曲和伸展。 旋转弧度，旋转频率和施加的力可以根据患者的需要而变化。 与前臂支撑结构相关联的是手腕稳定器，当前臂交替弯曲和伸展时，该稳定器引起手腕的交替的旋转和仰卧。 该装置还具有上臂支撑结构。

    SCHEDULING OF TASKS ON IDLE PROCESSORS WITHOUT CONTEXT SWITCHING
    9.
    发明申请
    SCHEDULING OF TASKS ON IDLE PROCESSORS WITHOUT CONTEXT SWITCHING 审中-公开
    在没有上下文切换的空闲处理器上调度任务

    公开(公告)号：US20150378782A1

    公开(公告)日：2015-12-31

    申请号：US14542727

    申请日：2014-11-17

    申请人： Chandan Hks ,  Sonika P. Reddy

    发明人： Chandan Hks ,  Sonika P. Reddy

    IPC分类号： G06F9/48

    CPC分类号： G06F9/4893 ,  G06F9/4887 ,  Y02D10/24

    摘要： Tasks may be scheduled on more than one processor to allow the processors to operate at lower processor frequencies and processor supply voltages. In particular, realtime tasks may be scheduled on idle processors without context switching an existing executing tasks. For example, a method of executing tasks on a plurality of processors may include receiving a new task with an earlier deadline than an executing task; determining whether an idle processor is available; and when an idle processor is available, executing the new task on the idle processor.

    摘要翻译： 可以在多个处理器上安排任务，以允许处理器在较低的处理器频率和处理器电源电压下工作。 特别地，可以在空闲处理器上调度实时任务，而无需上下文切换现有的执行任务。 例如，在多个处理器上执行任务的方法可以包括以比执行任务更早的期限接收新任务; 确定空闲处理器是否可用; 并且当空闲处理器可用时，在空闲处理器上执行新任务。

    FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS
    10.
    发明申请
    FUSED TRICYCLIC COMPOUNDS AS mTOR INHIBITORS 有权
    熔融三聚体化合物作为mTOR抑制剂

    公开(公告)号：US20140171456A1

    公开(公告)日：2014-06-19

    申请号：US14234837

    申请日：2012-07-20

    申请人： Zhaoyang Meng ,  Arshad Siddiqui ,  Panduranga Abdulla P. Reddy ,  Mehul F. Patel ,  Yang Nan

    发明人： Zhaoyang Meng ,  Arshad Siddiqui ,  Panduranga Abdulla P. Reddy ,  Mehul F. Patel ,  Yang Nan

    IPC分类号： C07D487/14 ,  A61K31/519

    CPC分类号： C07D487/14 ,  A61K31/519 ,  C07D519/00

    摘要： The present invention relates to certain pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine and dipyrazolopyrimidine compounds of Formula (I) as inhibitors of mammalian Target Of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP. The compounds may be used in the treatment of cancer and other disorders where mTOR is deregulated. The present invention further provides pharmaceutical compositions comprising the pyrazolo[1,5-a]pyrrolo[3,2-e]pyrimidine or dipyrazolopyrimidine compounds.

    摘要翻译： 本发明涉及式（I）的某些吡唑并[1,5-a]吡咯并[3,2-e]嘧啶和二吡唑并嘧啶化合物作为哺乳动物雷帕霉素靶标（mTOR）激酶的抑制剂，其也称为FRAP， RAFT，RAPT或SEP。 所述化合物可用于治疗其中mTOR失调的癌症和其它病症。 本发明还提供包含吡唑并[1,5-a]吡咯并[3,2-e]嘧啶或二吡唑并嘧啶化合物的药物组合物。